We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
philip.bejon@ndm.ox.ac.uk

Philip Bejon

Director Modernising Medical Microbiology

I was Director of the KEMRI-Wellcome Trust Research Programme up to January 2024, and was based in Kenya for 10 years. I am now based in Oxford, as Director of the Modernising Medical Microbiology Unit, where I work on antimicrobial resistance, bone infection, and pathogen genomics. I continue to work with colleagues based in Kenya on controlled human malaria infection studies, and on evaluations of malaria vaccines in the field, on validating definitions of severe malaria, studies of naturally acquired immunity to malaria, evaluations of Ebola and Yellow Fever vaccines, and on the epidemiology and immunology of COVID in Kenya.

Visit Philip's profile page for Modernising Medical Microbiology

Recent publications

Widespread Variants of the Highly Polymorphic Plasmodium falciparum Vaccine Candidate Antigen MSP2 Across Sub-Saharan Africa

Zerebinski J. et al, (2026), The Journal of Infectious Diseases

Genomic Epidemiology of Multi-Modal ESBL Gene Transmission among Enterobacterales in a Neonatal Unit

Parker MJ. et al, (2026)

Controlled human malaria infection in adults identify combinations of merozoite antigens associated with clinical immunity.

Ogwang R. et al, (2026), Nature communications

African-specific genetic loci determine iron status and risk of severe malaria and bacteremia in African children.

Muriuki JM. et al, (2026), Nature communications, 17

Longitudinal Epidemiology and Variant Dynamics of SARS-CoV-2 in Coastal Kenya (2020–2025): Clinical Features and Wave Patterns

Lambisia AW. et al, (2026), Open Forum Infectious Diseases, 13